FDA delays decision on Merus' first-in-class cancer drug by 3 months 0 05.11.2024 17:15 Fiercebiotech.com FDA delays decision on Merus' first-in-class cancer drug by 3 months ntaylor Tue, 11/05/2024 - 09:15
